menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Interventions Targeting Impaired Glucose Tolerance

close
Interventions Targeting Impaired Glucose Tolerance
RestartResume
Choose a format
Media formats available:
Details
Presenters
Comments
  • Overview

    The ACT NOW study examined whether treatment of impaired glucose tolerance in pre-diabetic patients with pioglitazone could prevent or delay the development of type 2 diabetes. Join host Dr. Steven Edelman and his guest, endocrinologist and professor of medicine at the University of California San Diego, Dr. Robert Henry, as they discuss the results and implications for clinical care.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    The ACT NOW study examined whether treatment of impaired glucose tolerance in pre-diabetic patients with pioglitazone could prevent or delay the development of type 2 diabetes. Join host Dr. Steven Edelman and his guest, endocrinologist and professor of medicine at the University of California San Diego, Dr. Robert Henry, as they discuss the results and implications for clinical care.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 2/27/20